These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 23241526)
1. Survival analysis of breast cancer patients using Cox and frailty models. Faradmal J; Talebi A; Rezaianzadeh A; Mahjub H J Res Health Sci; 2012 Dec; 12(2):127-30. PubMed ID: 23241526 [TBL] [Abstract][Full Text] [Related]
2. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients]. Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207 [TBL] [Abstract][Full Text] [Related]
3. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis. Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI Breast J; 2006; 12(1):37-47. PubMed ID: 16409585 [TBL] [Abstract][Full Text] [Related]
4. Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series. Truong PT; Lesperance M; Li KH; MacFarlane R; Speers CH; Chia S Ann Surg Oncol; 2010 Aug; 17(8):2138-46. PubMed ID: 20151215 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the number of positive lymph nodes in women with T1-2N1 breast cancer treated with mastectomy: should patients with 1, 2, and 3 positive lymph nodes be grouped together? Dai Kubicky C; Mongoue-Tchokote S Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1200-5. PubMed ID: 23265570 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in gastric cancer using log-normal censored regression model. Pourhoseingholi MA; Moghimi-Dehkordi B; Safaee A; Hajizadeh E; Solhpour A; Zali MR Indian J Med Res; 2009 Mar; 129(3):262-7. PubMed ID: 19491418 [TBL] [Abstract][Full Text] [Related]
7. Recurrence in breast cancer. Analysis with frailty model. Gohari MR; Mahmoudi M; Mohammed K; Pasha E; Khodabakhshi R Saudi Med J; 2006 Aug; 27(8):1187-93. PubMed ID: 16883450 [TBL] [Abstract][Full Text] [Related]
8. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality. Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K J BUON; 2015; 20(3):737-45. PubMed ID: 26214625 [TBL] [Abstract][Full Text] [Related]
9. A comparison of breast cancer survival among young, middle-aged, and elderly patients in southern Iran using Cox and empirical Bayesian additive hazard models. Nematolahi S; Ayatollahi SMT Epidemiol Health; 2017; 39():e2017043. PubMed ID: 29056033 [TBL] [Abstract][Full Text] [Related]
10. Ratios of involved nodes in early breast cancer. Vinh-Hung V; Verschraegen C; Promish DI; Cserni G; Van de Steene J; Tai P; Vlastos G; Voordeckers M; Storme G; Royce M Breast Cancer Res; 2004; 6(6):R680-8. PubMed ID: 15535850 [TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and survival analysis of 22 cases of pure epithelial breast metaplastic carcinoma]. Meng HM; Yang YF; Qi LQ; Gu L Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):525-9. PubMed ID: 24257306 [TBL] [Abstract][Full Text] [Related]
12. The prognostic value of lymph node ratio in node-positive breast cancer: a Dutch nationwide population-based study. Dings PJ; Elferink MA; Strobbe LJ; de Wilt JH Ann Surg Oncol; 2013 Aug; 20(8):2607-14. PubMed ID: 23536053 [TBL] [Abstract][Full Text] [Related]
13. Impact of the obesity on lymph node status in operable breast cancer patients. Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Solak M; Turkoz FP; Arik Z; Esin E; Petekkaya I; Altundag K J BUON; 2013; 18(4):824-30. PubMed ID: 24344004 [TBL] [Abstract][Full Text] [Related]
14. The prognostic influence of multifocality in breast cancer patients. Pedersen L; Gunnarsdottir KA; Rasmussen BB; Moeller S; Lanng C Breast; 2004 Jun; 13(3):188-93. PubMed ID: 15177420 [TBL] [Abstract][Full Text] [Related]
15. The lymph node ratio as prognostic factor in node-positive breast cancer. Voordeckers M; Vinh-Hung V; Van de Steene J; Lamote J; Storme G Radiother Oncol; 2004 Mar; 70(3):225-30. PubMed ID: 15064006 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma. Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929 [TBL] [Abstract][Full Text] [Related]
17. Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society. Ahn SH; Kim HJ; Lee JW; Gong GY; Noh DY; Yang JH; Jung SS; Park HY Breast Cancer Res Treat; 2011 Nov; 130(2):507-15. PubMed ID: 21858659 [TBL] [Abstract][Full Text] [Related]
18. The impact of method of biopsy on the incidence of breast cancer sentinel lymph node metastases. Meattini I; Giannotti E; Abdulcadir D; Saieva C; Guerrieri AM; Vanzi E; Scartoni D; Cecchini S; Sanchez LJ; Orzalesi L; Casella D; Bianchi S; Livi L; Nori J Eur J Surg Oncol; 2014 Mar; 40(3):277-81. PubMed ID: 24388742 [TBL] [Abstract][Full Text] [Related]
19. Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer. Vinh-Hung V; Burzykowski T; Cserni G; Voordeckers M; Van De Steene J; Storme G Int J Oncol; 2003 Mar; 22(3):697-704. PubMed ID: 12579326 [TBL] [Abstract][Full Text] [Related]
20. Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences. Oven Ustaalioglu BB; Bilici A; Kefeli U; Seker M; Yildirim E; Salepci T; Oncel M; Kement M; Gumus M Oncology; 2010; 79(1-2):105-11. PubMed ID: 21088436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]